 |
PDBsum entry 1b09
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
1b09
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure Fold Des
7:169-177
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
The physiological structure of human C-reactive protein and its complex with phosphocholine.
|
|
D.Thompson,
M.B.Pepys,
S.P.Wood.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Human C-reactive protein (CRP) is the classical acute phase
reactant, the circulating concentration of which rises rapidly and extensively
in a cytokine-mediated response to tissue injury, infection and inflammation.
Serum CRP values are routinely measured, empirically, to detect and monitor many
human diseases. However, CRP is likely to have important host defence,
scavenging and metabolic functions through its capacity for calcium-dependent
binding to exogenous and autologous molecules containing phosphocholine (PC) and
then activating the classical complement pathway. CRP may also have pathogenic
effects and the recent discovery of a prognostic association between increased
CRP production and coronary atherothrombotic events is of particular interest.
RESUTLS: The X-ray structures of fully calcified C-reactive protein, in the
presence and absence of bound PC, reveal that although the subunit beta-sheet
jellyroll fold is very similar to that of the homologous pentameric protein
serum amyloid P component, each subunit is tipped towards the fivefold axis. PC
is bound in a shallow surface pocket on each subunit, interacting with the two
protein-bound calcium ions via the phosphate group and with Glu81 via the
choline moiety. There is also an unexpected hydrophobic pocket adjacent to the
ligand. CONCLUSIONS: The structure shows how large ligands containing PC may be
bound by CRP via a phosphate oxygen that projects away from the surface of the
protein. Multipoint attachment of one planar face of the CRP molecule to a
PC-bearing surface would leave available, on the opposite exposed face, the
recognition sites for C1q, which have been identified by mutagenesis. This would
enable CRP to target physiologically and/or pathologically significant
complement activation. The hydrophobic pocket adjacent to bound PC invites the
design of inhibitors of CRP binding that may have therapeutic relevance to the
possible role of CRP in atherothrombotic events.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 3.
Figure 3. Ribbon overlay of an SAP protomer (yellow) and a
CRP protomer (green) indicating the orientation of the protomers
with respect to the fivefold axis of the pentamers.
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure Fold Des
(1999,
7,
169-177)
copyright 1999.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.Mikolajek,
S.E.Kolstoe,
V.E.Pye,
P.Mangione,
M.B.Pepys,
and
S.P.Wood
(2011).
Structural basis of ligand specificity in the human pentraxins, C-reactive protein and serum amyloid P component.
|
| |
J Mol Recognit,
24,
371-377.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.L.Vincent,
K.Donadello,
and
X.Schmit
(2011).
Biomarkers in the critically ill patient: C-reactive protein.
|
| |
Crit Care Clin,
27,
241-251.
|
 |
|
|
|
|
 |
L.Baltzer
(2011).
Crossing borders to bind proteins-a new concept in protein recognition based on the conjugation of small organic molecules or short peptides to polypeptides from a designed set.
|
| |
Anal Bioanal Chem,
400,
1653-1664.
|
 |
|
|
|
|
 |
A.I.Okemefuna,
R.Nan,
A.Miller,
J.Gor,
and
S.J.Perkins
(2010).
Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations.
|
| |
J Biol Chem,
285,
1053-1065.
|
 |
|
|
|
|
 |
C.Frolet,
M.Beniazza,
L.Roux,
B.Gallet,
M.Noirclerc-Savoye,
T.Vernet,
and
A.M.Di Guilmi
(2010).
New adhesin functions of surface-exposed pneumococcal proteins.
|
| |
BMC Microbiol,
10,
190.
|
 |
|
|
|
|
 |
I.Zegers,
W.Schreiber,
S.Linstead,
M.Lammers,
M.McCusker,
A.Muñoz,
Y.Itoh,
G.Merlini,
S.Trapmann,
H.Emons,
J.Sheldon,
and
H.Schimmel
(2010).
Development and preparation of a new serum protein reference material: feasibility studies and processing.
|
| |
Clin Chem Lab Med,
48,
805-813.
|
 |
|
|
|
|
 |
O.Pible,
C.Vidaud,
S.Plantevin,
J.L.Pellequer,
and
E.Quéméneur
(2010).
Predicting the disruption by UO2(2+) of a protein-ligand interaction.
|
| |
Protein Sci,
19,
2219-2230.
|
 |
|
|
|
|
 |
R.M.van Ree,
S.Gross,
D.M.Zelle,
J.J.van der Heide,
J.P.Schouten,
W.J.van Son,
R.O.Gans,
and
S.J.Bakker
(2010).
Influence of C-reactive protein and urinary protein excretion on prediction of graft failure and mortality by serum albumin in renal transplant recipients.
|
| |
Transplantation,
89,
1247-1254.
|
 |
|
|
|
|
 |
S.Rajasekaran,
D.P.Jones,
Y.Avent,
M.L.Shaffer,
L.Elbahlawan,
N.Henderson,
R.C.Barfield,
R.R.Morrison,
and
R.F.Tamburro
(2010).
Outcomes of hematopoietic stem cell transplant patients who received continuous renal replacement therapy in a pediatric oncology intensive care unit.
|
| |
Pediatr Crit Care Med,
11,
699-706.
|
 |
|
|
|
|
 |
M.Yamada,
P.Mao,
J.Fu,
and
J.Han
(2009).
Rapid quantification of disease-marker proteins using continuous-flow immunoseparation in a nanosieve fluidic device.
|
| |
Anal Chem,
81,
7067-7074.
|
 |
|
|
|
|
 |
N.Bassi,
S.Zampieri,
A.Ghirardello,
M.Tonon,
M.Zen,
F.Cozzi,
and
A.Doria
(2009).
Pentraxins, Anti-pentraxin Antibodies, and Atherosclerosis.
|
| |
Clin Rev Allergy Immunol,
37,
36-43.
|
 |
|
|
|
|
 |
S.Devaraj,
U.Singh,
and
I.Jialal
(2009).
The evolving role of C-reactive protein in atherothrombosis.
|
| |
Clin Chem,
55,
229-238.
|
 |
|
|
|
|
 |
S.Tonstad,
and
J.L.Cowan
(2009).
C-reactive protein as a predictor of disease in smokers and former smokers: a review.
|
| |
Int J Clin Pract,
63,
1634-1641.
|
 |
|
|
|
|
 |
W.Ansar,
S.Mukhopadhyay,
S.K.Habib,
S.Basu,
B.Saha,
A.K.Sen,
C.N.Mandal,
and
C.Mandal
(2009).
Disease-associated glycosylated molecular variants of human C-reactive protein activate complement-mediated hemolysis of erythrocytes in tuberculosis and Indian visceral leishmaniasis.
|
| |
Glycoconj J,
26,
1151-1169.
|
 |
|
|
|
|
 |
Y.N.Peng,
Y.L.Ho,
C.Y.Wu,
and
M.Y.Liu
(2009).
Investigation of C-reactive protein binding to phosphatidyl choline by CZE and ESI-mass analysis.
|
| |
Electrophoresis,
30,
1564-1571.
|
 |
|
|
|
|
 |
A.Agrawal,
M.V.Suresh,
S.K.Singh,
and
D.A.Ferguson
(2008).
The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.
|
| |
Endocr Metab Immune Disord Drug Targets,
8,
231-237.
|
 |
|
|
|
|
 |
A.Inforzato,
V.Rivieccio,
A.P.Morreale,
A.Bastone,
A.Salustri,
L.Scarchilli,
A.Verdoliva,
S.Vincenti,
G.Gallo,
C.Chiapparino,
L.Pacello,
E.Nucera,
O.Serlupi-Crescenzi,
A.J.Day,
B.Bottazzi,
A.Mantovani,
R.De Santis,
and
G.Salvatori
(2008).
Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization.
|
| |
J Biol Chem,
283,
10147-10161.
|
 |
|
|
|
|
 |
A.Peisajovich,
L.Marnell,
C.Mold,
and
T.W.Du Clos
(2008).
C-reactive protein at the interface between innate immunity and inflammation.
|
| |
Expert Rev Clin Immunol,
4,
379-390.
|
 |
|
|
|
|
 |
C.Albrecht,
N.Kaeppel,
and
G.Gauglitz
(2008).
Two immunoassay formats for fully automated CRP detection in human serum.
|
| |
Anal Bioanal Chem,
391,
1845-1852.
|
 |
|
|
|
|
 |
C.L.Naessan,
W.Egge-Jacobsen,
R.W.Heiniger,
M.C.Wolfgang,
F.E.Aas,
A.Røhr,
H.C.Winther-Larsen,
and
M.Koomey
(2008).
Genetic and functional analyses of PptA, a phospho-form transferase targeting type IV pili in Neisseria gonorrhoeae.
|
| |
J Bacteriol,
190,
387-400.
|
 |
|
|
|
|
 |
F.Montecucco,
and
F.Mach
(2008).
New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor.
|
| |
Clin Interv Aging,
3,
341-349.
|
 |
|
|
|
|
 |
J.Lu,
L.L.Marnell,
K.D.Marjon,
C.Mold,
T.W.Du Clos,
and
P.D.Sun
(2008).
Structural recognition and functional activation of FcgammaR by innate pentraxins.
|
| |
Nature,
456,
989-992.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.M.Turu,
M.Slevin,
S.Matou,
D.West,
C.Rodríguez,
A.Luque,
M.Grau-Olivares,
L.Badimon,
J.Martinez-Gonzalez,
and
J.Krupinski
(2008).
C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression.
|
| |
BMC Cell Biol,
9,
47.
|
 |
|
|
|
|
 |
S.Hakobyan,
C.L.Harris,
C.W.van den Berg,
M.C.Fernandez-Alonso,
E.G.de Jorge,
S.R.de Cordoba,
G.Rivas,
P.Mangione,
M.B.Pepys,
and
B.P.Morgan
(2008).
Complement Factor H Binds to Denatured Rather than to Native Pentameric C-reactive Protein.
|
| |
J Biol Chem,
283,
30451-30460.
|
 |
|
|
|
|
 |
S.K.Singh,
M.V.Suresh,
D.C.Prayther,
J.P.Moorman,
A.E.Rusiñol,
and
A.Agrawal
(2008).
C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells.
|
| |
J Immunol,
180,
4316-4322.
|
 |
|
|
|
|
 |
S.K.Singh,
M.V.Suresh,
D.C.Prayther,
J.P.Moorman,
A.E.Rusiñol,
and
A.Agrawal
(2008).
Phosphoethanolamine-complexed C-reactive protein: a pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum.
|
| |
Clin Chim Acta,
394,
94-98.
|
 |
|
|
|
|
 |
C.Chou,
H.Y.Hsu,
H.T.Wu,
K.Y.Tseng,
A.Chiou,
C.J.Yu,
Z.Y.Lee,
and
T.S.Chan
(2007).
Fiber optic biosensor for the detection of C-reactive protein and the study of protein binding kinetics.
|
| |
J Biomed Opt,
12,
024025.
|
 |
|
|
|
|
 |
J.Wessel,
G.Moratorio,
F.Rao,
M.Mahata,
L.Zhang,
W.Greene,
B.K.Rana,
B.P.Kennedy,
S.Khandrika,
P.Huang,
E.O.Lillie,
P.A.Shih,
D.W.Smith,
G.Wen,
B.A.Hamilton,
M.G.Ziegler,
J.L.Witztum,
N.J.Schork,
G.W.Schmid-Schönbein,
and
D.T.O'Connor
(2007).
C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci.
|
| |
J Hypertens,
25,
329-343.
|
 |
|
|
|
|
 |
K.E.Taylor,
and
C.W.van den Berg
(2007).
Structural and functional comparison of native pentameric, denatured monomeric and biotinylated C-reactive protein.
|
| |
Immunology,
120,
404-411.
|
 |
|
|
|
|
 |
T.Kacira,
R.Kemerdere,
P.Atukeren,
H.Hanimoglu,
G.Z.Sanus,
M.Kucur,
T.Tanriverdi,
K.Gumustas,
and
M.Y.Kaynar
(2007).
Detection of caspase-3, neuron specific enolase, and high-sensitivity C-reactive protein levels in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage.
|
| |
Neurosurgery,
60,
674.
|
 |
|
|
|
|
 |
V.M.Leppänen,
H.Tossavainen,
P.Permi,
L.Lehtiö,
G.Rönnholm,
A.Goldman,
I.Kilpelaïnen,
and
T.Pihlajamaa
(2007).
Crystal structure of the N-terminal NC4 domain of collagen IX, a zinc binding member of the laminin-neurexin-sex hormone binding globulin (LNS) domain family.
|
| |
J Biol Chem,
282,
23219-23230.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.M.Okino,
C.Bürger,
J.R.Cardoso,
E.L.Lavado,
P.A.Lotufo,
and
A.Campa
(2006).
The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates.
|
| |
Mediators Inflamm,
2006,
47297.
|
 |
|
|
|
|
 |
A.Pfützner,
and
T.Forst
(2006).
High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus.
|
| |
Diabetes Technol Ther,
8,
28-36.
|
 |
|
|
|
|
 |
M.B.Pepys,
G.M.Hirschfield,
G.A.Tennent,
J.R.Gallimore,
M.C.Kahan,
V.Bellotti,
P.N.Hawkins,
R.M.Myers,
M.D.Smith,
A.Polara,
A.J.Cobb,
S.V.Ley,
J.A.Aquilina,
C.V.Robinson,
I.Sharif,
G.A.Gray,
C.A.Sabin,
M.C.Jenvey,
S.E.Kolstoe,
D.Thompson,
and
S.P.Wood
(2006).
Targeting C-reactive protein for the treatment of cardiovascular disease.
|
| |
Nature,
440,
1217-1221.
|
 |
|
|
|
|
 |
R.T.Lee,
and
Y.C.Lee
(2006).
Carbohydrate ligands of human C-reactive protein: binding of neoglycoproteins containing galactose-6-phosphate and galactose-terminated disaccharide.
|
| |
Glycoconj J,
23,
317-327.
|
 |
|
|
|
|
 |
S.Lin,
C.K.Lee,
Y.M.Wang,
L.S.Huang,
Y.H.Lin,
S.Y.Lee,
B.C.Sheu,
and
S.M.Hsu
(2006).
Measurement of dimensions of pentagonal doughnut-shaped C-reactive protein using an atomic force microscope and a dual polarisation interferometric biosensor.
|
| |
Biosens Bioelectron,
22,
323-327.
|
 |
|
|
|
|
 |
J.A.Hermoso,
L.Lagartera,
A.González,
M.Stelter,
P.García,
M.Martínez-Ripoll,
J.L.García,
and
M.Menéndez
(2005).
Insights into pneumococcal pathogenesis from the crystal structure of the modular teichoic acid phosphorylcholine esterase Pce.
|
| |
Nat Struct Mol Biol,
12,
533-538.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.K.Venugopal,
S.Devaraj,
and
I.Jialal
(2005).
Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role.
|
| |
Curr Opin Nephrol Hypertens,
14,
33-37.
|
 |
|
|
|
|
 |
S.K.Venugopal,
S.Devaraj,
and
I.Jialal
(2005).
Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects.
|
| |
Am J Pathol,
166,
1265-1271.
|
 |
|
|
|
|
 |
C.Gaboriaud,
N.M.Thielens,
L.A.Gregory,
V.Rossi,
J.C.Fontecilla-Camps,
and
G.J.Arlaud
(2004).
Structure and activation of the C1 complex of complement: unraveling the puzzle.
|
| |
Trends Immunol,
25,
368-373.
|
 |
|
|
|
|
 |
C.Sjöwall,
A.A.Bengtsson,
G.Sturfelt,
and
T.Skogh
(2004).
Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.
|
| |
Arthritis Res Ther,
6,
R87-R94.
|
 |
|
|
|
|
 |
G.F.Ferraccioli,
and
E.Gremese
(2004).
Autoantibodies and thrombophilia in RA: TNFalpha and TNFalpha blockers.
|
| |
Ann Rheum Dis,
63,
613-615.
|
 |
|
|
|
|
 |
L.A.Omtvedt,
T.N.Wien,
T.Myran,
K.Sletten,
and
G.Husby
(2004).
Serum amyloid P component in mink, a non-glycosylated protein with affinity for phosphorylethanolamine and phosphorylcholine.
|
| |
Amyloid,
11,
101-108.
|
 |
|
|
|
|
 |
M.Seto,
M.Whitlow,
M.A.McCarrick,
S.Srinivasan,
Y.Zhu,
R.Pagila,
R.Mintzer,
D.Light,
A.Johns,
and
J.A.Meurer-Ogden
(2004).
A model of the acid sphingomyelinase phosphoesterase domain based on its remote structural homolog purple acid phosphatase.
|
| |
Protein Sci,
13,
3172-3186.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.V.Suresh,
S.K.Singh,
and
A.Agrawal
(2004).
Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications.
|
| |
J Biol Chem,
279,
52552-52557.
|
 |
|
|
|
|
 |
S.Y.Seong,
and
P.Matzinger
(2004).
Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.
|
| |
Nat Rev Immunol,
4,
469-478.
|
 |
|
|
|
|
 |
U.Kishore,
C.Gaboriaud,
P.Waters,
A.K.Shrive,
T.J.Greenhough,
K.B.Reid,
R.B.Sim,
and
G.J.Arlaud
(2004).
C1q and tumor necrosis factor superfamily: modularity and versatility.
|
| |
Trends Immunol,
25,
551-561.
|
 |
|
|
|
|
 |
C.Gaboriaud,
J.Juanhuix,
A.Gruez,
M.Lacroix,
C.Darnault,
D.Pignol,
D.Verger,
J.C.Fontecilla-Camps,
and
G.J.Arlaud
(2003).
The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties.
|
| |
J Biol Chem,
278,
46974-46982.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.T.Yeh,
and
R.P.Palusinski
(2003).
C-reactive protein: the pawn has been promoted to queen.
|
| |
Curr Atheroscler Rep,
5,
101-105.
|
 |
|
|
|
|
 |
M.B.Pepys,
and
G.M.Hirschfield
(2003).
C-reactive protein: a critical update.
|
| |
J Clin Invest,
111,
1805-1812.
|
 |
|
|
|
|
 |
N.Diaz Padilla,
W.K.Bleeker,
Y.Lubbers,
G.M.Rigter,
G.J.Van Mierlo,
M.R.Daha,
and
C.E.Hack
(2003).
Rat C-reactive protein activates the autologous complement system.
|
| |
Immunology,
109,
564-571.
|
 |
|
|
|
|
 |
S.J.Kim,
D.Gershov,
X.Ma,
N.Brot,
and
K.B.Elkon
(2003).
Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses.
|
| |
Ann N Y Acad Sci,
987,
68-78.
|
 |
|
|
|
|
 |
B.Y.Kwak,
Y.M.Zhang,
M.Yun,
R.J.Heath,
C.O.Rock,
S.Jackowski,
and
H.W.Park
(2002).
Structure and mechanism of CTP:phosphocholine cytidylyltransferase (LicC) from Streptococcus pneumoniae.
|
| |
J Biol Chem,
277,
4343-4350.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.B.Bodman-Smith,
A.J.Melendez,
I.Campbell,
P.T.Harrison,
J.M.Allen,
and
J.G.Raynes
(2002).
C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI).
|
| |
Immunology,
107,
252-260.
|
 |
|
|
|
|
 |
R.T.Lee,
I.Takagahara,
and
Y.C.Lee
(2002).
Mapping the binding areas of human C-reactive protein for phosphorylcholine and polycationic compounds. Relationship between the two types of binding sites.
|
| |
J Biol Chem,
277,
225-232.
|
 |
|
|
|
|
 |
M.Arici,
and
J.Walls
(2001).
End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?
|
| |
Kidney Int,
59,
407-414.
|
 |
|
|
|
|
 |
D.Gershov,
S.Kim,
N.Brot,
and
K.B.Elkon
(2000).
C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity.
|
| |
J Exp Med,
192,
1353-1364.
|
 |
|
|
|
|
 |
M.Noursadeghi,
M.C.Bickerstaff,
J.R.Gallimore,
J.Herbert,
J.Cohen,
and
M.B.Pepys
(2000).
Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen.
|
| |
Proc Natl Acad Sci U S A,
97,
14584-14589.
|
 |
|
|
|
|
 |
J.A.Glomset
(1999).
Protein-lipid interactions on the surfaces of cell membranes.
|
| |
Curr Opin Struct Biol,
9,
425-427.
|
 |
|
|
|
|
 |
J.Bouckaert,
T.Hamelryck,
L.Wyns,
and
R.Loris
(1999).
Novel structures of plant lectins and their complexes with carbohydrates.
|
| |
Curr Opin Struct Biol,
9,
572-577.
|
 |
|
|
|
|
 |
M.Griselli,
J.Herbert,
W.L.Hutchinson,
K.M.Taylor,
M.Sohail,
T.Krausz,
and
M.B.Pepys
(1999).
C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction.
|
| |
J Exp Med,
190,
1733-1740.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |